2026-06-07 Drugs SFDA Grants Orphan Drug Designation to “Gomekli” for the Treatment of Neurofibromatosis Type 1 (NF1)
2026-06-05 The Authority SFDA: AI-Powered 'RASID' Service Cuts Controlled Medication Verification Time for Hajj Pilgrims by 98%
2026-06-04 Drugs The SFDA Grants Breakthrough Designation to "ZENBEXUS" for the Treatment of Adult Patients with Multiple Myeloma
2026-05-29 The Authority SFDA CEO Congratulates the Leadership on the Success of the 1447 AH Hajj Season
2026-05-27 The Authority SFDA CEO Extends Congratulations to the Wise Leadership on the Occasion of Eid al-Adha
2026-05-24 The Authority, Drugs SFDA Grants Breakthrough Designation to Prevent and Reduce Bleeding Episodes in Patients with Hemophilia A
2026-05-23 The Authority Minister of Health Visits SFDA's Hajj Operations Center and Inspects Service Readiness
2026-05-22 The Authority SFDA CEO Reviews the Authority's Readiness to Serve Pilgrims and Inspects Facilities in Makkah
2026-05-21 The Authority Immediate 24/7 Response: SFDA's Hajj Operations Center Plays a Pivotal Role in Enhancing Pilgrim Safety
